1. Home
  2. ACCO vs GLSI Comparison

ACCO vs GLSI Comparison

Compare ACCO & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$3.83

Market Cap

361.7M

ML Signal

HOLD

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$27.81

Market Cap

327.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCO
GLSI
Founded
1893
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.7M
327.2M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
ACCO
GLSI
Price
$3.83
$27.81
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$50.00
AVG Volume (30 Days)
926.4K
100.3K
Earning Date
04-30-2026
05-19-2026
Dividend Yield
9.26%
N/A
EPS Growth
141.51
N/A
EPS
0.20
N/A
Revenue
$1,524,700,000.00
N/A
Revenue This Year
$3.10
N/A
Revenue Next Year
$0.89
N/A
P/E Ratio
$19.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.81
$7.78
52 Week High
$4.30
$34.10

Technical Indicators

Market Signals
Indicator
ACCO
GLSI
Relative Strength Index (RSI) 57.54 60.93
Support Level $3.82 $20.86
Resistance Level $4.20 $29.89
Average True Range (ATR) 0.13 1.66
MACD -0.03 0.44
Stochastic Oscillator 29.96 82.70

Price Performance

Historical Comparison
ACCO
GLSI

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

Share on Social Networks: